首页> 外文OA文献 >Synthesis, biological evaluation and structure-activity relationships of N-benzoyl-2-hydroxybenzamides as agents active against P. falciparum (K1 strain), Trypanosomes, and Leishmania
【2h】

Synthesis, biological evaluation and structure-activity relationships of N-benzoyl-2-hydroxybenzamides as agents active against P. falciparum (K1 strain), Trypanosomes, and Leishmania

机译:N-苯甲酰基-2-羟基苯甲酰胺作为抗恶性疟原虫(K1菌株),锥虫和利什曼原虫的活性剂的合成,生物学评价和构效关系

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In our efforts to identify novel chemical scaffolds for the development of new anti-protozoal drugs, a compound library was screened against T. gondii tachyzoites with activity discovered for N-(4-ethylbenzoyl)-2-hydroxybenzamide 1a against T. gondii as described elsewhere.1 Synthesis of a compound set was guided by T. gondii SAR with 1r found to be superior for T. gondii, also active against Thai and Sierra Leone strains of P. falciparum, and with superior ADMET properties as described elsewhere.1 Herein, synthesis methods and details of the chemical analysis of the compounds in this series are described. Further, this series of N-benzoyl-2-hydroxybenzamides was re-purposed for testing against four other protozoan parasites: T. b. rhodesiense, T. cruzi, L. donovani, and P. falciparum (K1 isolate). Structure-activity analyses led to the identification of compounds in this set with excellent anti-leishmanial activity (compound 1d). Overall, compound 1r was the best and had activity 21-fold superior to that of the standard anti-malarial drug chloroquine against the K1 P. falciparum isolate
机译:在我们努力确定用于开发新的抗原生动物药物的新型化学支架的过程中,筛选了一种针对弓形虫速殖子的化合物文库,该化合物具有针对弓形虫的N-(4-乙基苯甲酰基)-2-羟基苯甲酰胺1a的活性,如上所述。 1刚德弓形虫SAR指导化合物的合成,发现1r优于刚地弓形虫,也对恶性疟原虫的泰国和塞拉利昂菌株具有活性,并具有其他地方所述的优异ADMET特性。1描述了该系列化合物的合成方法和化学分析的细节。此外,该系列的N-苯甲酰基-2-羟基苯甲酰胺被重新用于检测其他四种原生动物寄生虫:T。b.。 Rhodesiense,T。cruzi,L。donovani和P. falciparum(K1分离株)。结构活性分析导致鉴定出该化合物中具有优异的抗利什曼活性的化合物(化合物1d)。总体而言,化合物1r对K1恶性疟原虫分离物的活性最高,其活性比标准抗疟疾药物氯喹高21倍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号